April 02, 2025

Donanemab: Amyloid-Related Imaging Abnormalities

"ARIA is an adverse event associated with donanemab treatment that requires safety monitoring."

Conexiant

April 02, 2025

New Antibody Lowers COVID-19 Cases in Trial

Sipavibart reduced symptomatic COVID-19 by 34.9% compared to standard treatment, but efficacy was only observed against non–Phe456Leu-containing variants, according to new phase 3 trial data.

Conexiant

April 02, 2025

Do NSAIDs Prevent Dementia?

Long-term anti-inflammatory use linked to 12% reduced dementia risk in 14-year population study.

Conexiant

April 02, 2025

From Refugee to Resident

How Sophia Bellegarde overcame the odds to become a pathologist

The Pathologist

April 02, 2025

Herpes Zoster Vaccine May Lower Dementia Risk

"If these findings are truly causal, the zoster vaccine will be both far more effective as well as cost-effective in preventing or delaying dementia."

Conexiant

April 01, 2025

Coding: Reimbursement for OCT Angiography

The 2025, CPT Handbook contains a new procedure code for reporting OCT angiography (OCTA). This is a welcome addition to the list of codes for retinal scanning diagnostic services.

Ophthalmic Professional

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 31, 2025

Cold Plunges: A Cellular Reset?

New research shows that 1 week of daily cold-water immersion enhances autophagy and reduces cell death signals.

Conexiant

March 31, 2025

Microplastics Linked to Cardiovascular Disease

Research reveals significant associations between environmental microplastic pollution and increased rates of hypertension, diabetes, and stroke across U.S. coastal communities, with pollution levels ranking among top predictors for chronic disease prevalence.

Conexiant